Certified by Founder
Lodge
Calida Therapeutics
start up
France
- Ville de Paris, Île-de-France
- 07/04/2023
- Seed
- $2,183,000
Calida Therapeutics operates as a biotechnology company. Calida Therapeutics develops monoclonal antibodies to treat and prevent thrombo-inflammatory disorders.
- Industry Biotechnology Research
- Website N/A
- LinkedIn https://www.linkedin.com/company/calida-therapeutics/
Zero Homes | $16,800,000 | (Feb 19, 2026)
Rainfall Health | $15,000,000 | (Feb 19, 2026)
inKind | $450,000,000 | (Feb 19, 2026)
Avantos.ai | $25,000,000 | (Feb 19, 2026)
Korsana Biosciences | $175,000,000 | (Feb 19, 2026)
Vervesemi | $10,000,000 | (Feb 19, 2026)
DG Matrix | $60,000,000 | (Feb 19, 2026)
Synchrony Medical | $5,000,000 | (Feb 19, 2026)
Dataro | $14,280,000 | (Feb 18, 2026)
Sphinx(US) | $7,100,000 | (Feb 18, 2026)
The Compression Company | $3,400,000 | (Feb 18, 2026)
Helia Care, Inc. | $3,000,000 | (Feb 18, 2026)